Medication equivalent dose program in R

Citation: Shinsuke Koike, Yoji Hirano, Shinichiro Nakajima, Kentaro Morita, Medication equivalent dose program in R, Psychiatry and Clinical Neurosciences, 79(6), 356-357, 2025-03-31, https://doi.org/10.1111/pcn.1381

Abnormal spontaneous activity and rest-task shift in schizophrenia.

Schizophrenia (SZ) is associated with abnormalities in both spontaneous and task-evoked neural oscillations, and growing evidence shows that shift patterns of oscillatory activity between resting and task states are also disturbed. However, no study has simultaneously examined the frequency- and state-specific characteristics of oscillatory deficits in SZ. Using an auditory steady-state response (ASSR) paradigm, we aimed to examine the differential sensitivity of oscillatory measures to SZ and to assess rest-task shifts across multiple frequency bands./We recorded resting-state activity and 40 Hz ASSR of 66 neurotypical controls (NC) and 68 SZ patients using electroencephalography (EEG). 40 Hz stimulus-evoked activity was measured using evoked power, phase-locking factor (PLF), and phase-locking angle, whereas multi-frequency (4-100 Hz) spontaneous activity during ASSR and resting states was assessed using induced and resting power. The state-dependent shifts in spontaneous activity between the resting and ASSR states were evaluated over a broad frequency range./Both induced and resting power in the low-frequency range (4-10 Hz) were elevated over widespread regions in SZ patients relative to NC. Gamma-band (39-100 Hz) induced power then demonstrated excellent ability to discriminate between SZ and NC. In addition, SZ patients showed a reduced rest-task shift in the theta-beta band (5-23 Hz) spontaneous power, most pronounced in the alpha-band (8-13 Hz)./The present study confirmed the utility of gamma-band induced power during ASSR stimulation for differentiating SZ patients from NC. Importantly, our results also highlight the pathophysiological significance of the reduced rest-task shift pattern of spontaneous activity mainly in the alpha-band in SZ patients

Gamma and Theta/Alpha-Band Oscillations in the Electroencephalogram Distinguish the Content of Inner Speech

Inner speech refers to the silent production of language in one’s mind. As a purely mental action without obvious physical manifestations, inner speech has been notoriously difficult to quantify. To address this issue, the present study repurposed the phenomenon of speaking-induced suppression, wherein overt speech has been consistently shown to elicit reduced auditory evoked potentials compared with externally generated speech, as well as changes in oscillatory activity in gamma and theta frequency bands. Given the functional similarities between inner and overt speech, we used an established experimental protocol to investigate whether similar metrics could be used to distinguish the content of inner speech. Healthy participants (n = 129) produced an inner syllable at a precisely specified time. An audible syllable was concurrently presented which either matched or mismatched the content of the inner syllable. The results revealed that Match and Mismatch conditions could be differentiated on the basis of their evoked oscillations in the gamma, theta, and alpha bands. Notably, there was a gamma-band oscillation in the vicinity of the P2 that differed between the Match and Mismatch conditions, suggesting that “late” gamma-band activity may index consciously perceived expectancy violations, or cognitive prediction errors. Regarding the auditory evoked potentials, the N1 component was suppressed in the Match condition while the P2 component was suppressed in the Mismatch condition, replicating previous findings. This study provides support for the existence of “inner speaking-induced suppression”, and demonstrates that inner syllables can be differentiated based on their influence on the electroencephalographic activity elicited by simultaneously-presented audible syllables

Development of a questionnaire for evaluating supporters’ skills in Hikikomori support

Enhancing the skills of hikikomori supporters inherently contributes to improving the quality of support provided. However, a comprehensive skills assessment tool for these supporters has not yet been developed. This study aimed to develop a self-rated questionnaire, the Hikikomori Supporter’s Skills Checklist (HSSC). Based on a preliminary survey involving 43 supporters, the HSSC draft was revised. The revised version comprises 39 items addressing various aspects of consultation support. In the main survey, questionnaires were posted to 118 hikikomori community support centers. To assess convergent and discriminant validity and derive clinical insights, respondents completed the HSSC along with measures of stigmatic attitudes toward hikikomori and psychiatric patients, workplace psychological flexibility, burnout, and demographics, including prior experience in hikikomori-related learning and support. Analysis of 238 valid responses revealed a single-factor structur

Role of orexin receptors in histamine- and chloroquine-induced pruriceptive processing

It is known that orexin peptides are involved in nociceptive processing, while little is known about the roles of these peptides in itch processing. To reveal the functions of orexin peptides in pruriceptive processing, orexin A (OX-A) and orexin B (OX-B) were applied before histamine or chloroquine (CQ). The administration of OX-A reduced the numbers of scratching events and c-Fos positive cells induced by histamine and CQ, but not OX-B. To clarify the involvement of orexin receptors in pruriceptive processing, OX-A was administered after the injection of an orexin receptor type 1 (OX1) antagonist (SB334867) or an orexin receptor type 2 (OX2) antagonist (JNJ10397049) before histamine and CQ injections. The attenuating effects of OX-A on histamine- and CQ-induced scratching events were reversed by JNJ1039 and SB334867, respectively. To confirm the role of OX2 receptor, an OX2 receptor agonist (YNT185) was applied before the injection of histamine or CQ. Scratching events and c-Fos expression induced by histamine, but not CQ, were attenuated by the pretreatment with YNT185. These results indicate that OX-A elicits the attenuating effects in pruriceptive processing and that itch signals induced by histamine and CQ appear to be differentially regulated by the OX2 receptors and OX1 receptors

Differentiation between bipolar disorder and major depressive disorder based on AMPA receptor distribution.

An accurate diagnostic method using biological indicators is critically needed for bipolar disorder (BD) and major depressive disorder (MDD). The excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) is a crucial regulator of synaptic function, and its dysregulation may play a central role in the pathophysiology of psychiatric disorders. Our recently developed positron emission tomography (PET) tracer, [11C]K-2, enables the quantitative visualization of AMPAR distribution and is considered useful for characterizing synaptic phenotypes in patients with psychiatric disorders. This study aimed to develop a machine learning-based method to differentiate bipolar disorder from major depressive disorder using AMPAR density. Sixteen patients with BD and 27 patients with MDD, all in depressive episodes, underwent PET scans with [11C]K-2 and structural magnetic resonance imaging. AMPAR density was estimated using the standardized uptake value ratio from 30 to 50 min after tracer injection, normalized to whole brain radioactivity. A partial least squares model was trained to predict diagnoses based on AMPAR density, and its performance was evaluated using a leave-one-pair-out cross-validation. Significant differences in AMPAR density were observed in the parietal lobe, cerebellum, and frontal lobe, notably the dorsolateral prefrontal cortex between patients with BD and patients with MDD during a depressive episode. The model achieved an area under the curve of 0.80, sensitivity of 75.0%, and specificity of 77.8%. These findings suggest that AMPAR density measured with [11C]K-2 can effectively distinguish BD from MDD and may aid diagnosis, especially in patients with ambiguous symptoms or incomplete clinical presentation

Characterization of patients with major psychiatric disorders with AMPA receptor positron emission tomography

Synaptic phenotypes in living patients with psychiatric disorders are poorly characterized. Excitatory glutamate α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) is a fundamental component for neurotransmission. We recently developed a positron emission tomography (PET) tracer for AMPAR, [11C]K-2, the first technology to visualize and quantify AMPARs density in living human brain. In this study, we characterized patients with major psychiatric disorders with [11C]K-2. One hundred forty-nine patients with psychiatric disorders (schizophrenia, n = 42; bipolar disorder, n = 37; depression, n = 35; and autism spectrum disorder, n = 35) and 70 healthy participants underwent a PET scan with [11C]K-2 for measurement of AMPAR density. We detected brain regions that showed correlation between AMPAR density and symptomatology scores in each of four disorders. We also found brain areas with significant differences in AMPAR density between patients with each psychiatric disorder and healthy participants. Some of these areas were observed across diseases, indicating that these are commonly affected areas throughout psychiatric disorders. Schizophrenia, bipolar disorder, depression, and autism spectrum disorder are uniquely characterized by AMPAR distribution patterns. Our approach to psychiatric disorders using [11C]K-2 can elucidate the biological mechanisms across diseases and pave the way to develop novel diagnostics and therapeutics based on the synapse physiology

Production of Prompt Charmonia in e+e- Annihilation at sqrt[s] ≈ 10.6 GeV

journal articl

Networked Digital Library of Theses and Dissertations

video/mp4講演者所属: ヴァージニア工科大学教授vide

正誤表

othe